Jefferies Downgrades Salix Pharmaceuticals As Raised Bid By Valeant Appears Final
March 18, 2015 at 10:03 AM EDT
In a report published Wednesday, Jefferies analyst David Steinberg downgraded the rating on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ...